
GuiZhou SanLi Pharmaceutical Co.,Ltd
SSE:603439.SS
12.16 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities: | ||||||||||||
Net Income
| 279.838 | 292.703 | 191.938 | 148.601 | 93.951 | 133.07 | 110.48 | 87.628 | 74.88 | 52.61 | 28.994 | 19.373 |
Depreciation & Amortization
| 76.018 | 36.9 | 16.193 | 11.175 | 8.113 | 7.539 | 7.607 | 7.336 | 6.98 | 1.7 | 2.138 | 1.897 |
Deferred Income Tax
| 0 | 0 | -0.041 | -0.364 | -0.081 | -0.765 | 0 | 0 | 0 | 0 | 0 | 0 |
Stock Based Compensation
| 0 | 0 | 6.301 | 0.757 | 0.081 | 0.765 | 0 | 0 | 0 | 0 | 0 | 0 |
Change In Working Capital
| -275.853 | -16.266 | 72.191 | 2.716 | -40.471 | -26.05 | -46.385 | -38.119 | -50.512 | -2.768 | -31.014 | 5.157 |
Accounts Receivables
| -295.557 | -124.066 | -79.555 | -83.037 | -33.949 | -48.225 | -5.222 | -57.321 | -50.784 | 16.843 | -3.98 | 0 |
Inventory
| -147.988 | -7.059 | -9.455 | -41.126 | 5.832 | -1.462 | -7.771 | 14.274 | 0.645 | -19.611 | -5.67 | -23.806 |
Accounts Payables
| 0 | 119.02 | 161.241 | 127.243 | -12.274 | 24.402 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Working Capital
| 167.692 | -4.161 | -0.041 | -0.364 | -0.081 | -0.765 | -38.615 | -52.394 | -51.156 | 0 | -25.344 | 28.962 |
Other Non Cash Items
| 27.07 | -36.636 | 6.702 | -7.847 | 1.654 | 1.68 | 3.644 | 0.621 | 3.752 | -54.31 | 0.446 | 3.659 |
Operating Cash Flow
| 107.073 | 276.701 | 293.286 | 155.037 | 63.247 | 116.238 | 75.347 | 57.466 | 35.099 | 33.278 | 0.563 | 30.086 |
Investing Activities: | ||||||||||||
Investments In Property Plant And Equipment
| -45.198 | -108.735 | -119.906 | -26.077 | -51.708 | -8.011 | -1.785 | -7.173 | -12.36 | -50.527 | -26.289 | -8.766 |
Acquisitions Net
| 0 | -543.038 | -159.387 | 2.25 | 0 | 1.918 | 0 | -2.8 | 0.363 | 51.113 | 26.289 | 0 |
Purchases Of Investments
| -88.661 | -187 | 0 | -2.25 | -111.9 | 0 | -45.9 | -2.8 | -2.978 | -98.242 | -206.759 | 0 |
Sales Maturities Of Investments
| 1.612 | 1.453 | 1.919 | 64.618 | 0.799 | 0 | 0 | 0.782 | 0 | 123.398 | 182.174 | 0 |
Other Investing Activites
| 29.249 | 223.539 | 10.813 | -17.95 | -130 | -8.011 | 0.09 | 2.8 | 0.363 | -50.527 | -26.289 | 0.003 |
Investing Cash Flow
| -102.999 | -613.781 | -266.56 | 20.591 | -292.809 | -6.093 | -47.595 | -9.191 | -14.974 | -24.784 | -50.874 | -8.763 |
Financing Activities: | ||||||||||||
Debt Repayment
| 51.369 | 299 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | -60.6 | 29.6 | 0 |
Common Stock Issued
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock Repurchased
| 0 | -30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Dividends Paid
| -104.044 | -40.986 | -8.925 | -101.831 | -2.622 | 0 | -70.384 | -44.861 | -64.088 | -0.604 | -2.368 | -1.183 |
Other Financing Activities
| -47.926 | 109.617 | 0 | 18.17 | 442.62 | -1.96 | -6.4 | -0.228 | 202.559 | 55 | 10.83 | 3 |
Financing Cash Flow
| -100.601 | 337.631 | -0.125 | -81.461 | 439.998 | -1.96 | -76.784 | -45.09 | 138.471 | -6.204 | 38.062 | 1.817 |
Other Information: | ||||||||||||
Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | -0 | 0 | 0 | 0 |
Net Change In Cash
| -96.527 | 0.551 | 26.601 | 94.168 | 210.436 | 108.185 | -49.032 | 3.185 | 158.596 | 1.991 | -12.248 | 23.14 |
Cash At End Of Period
| 474.843 | 571.37 | 570.819 | 544.218 | 450.051 | 239.615 | 131.43 | 180.462 | 177.277 | 18.682 | 16.69 | 28.939 |